Global Angiotensin Receptor Blockers (ARBs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Angiotensin Receptor Blockers (ARBs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Angiotensin Receptor Blockers (ARBs) industry chain, the market status of Hypertension (Valsartan, Telmisartan), Cardiovascular Diseases (Valsartan, Telmisartan), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Angiotensin Receptor Blockers (ARBs).
Regionally, the report analyzes the Angiotensin Receptor Blockers (ARBs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Angiotensin Receptor Blockers (ARBs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Angiotensin Receptor Blockers (ARBs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Angiotensin Receptor Blockers (ARBs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Valsartan, Telmisartan).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Angiotensin Receptor Blockers (ARBs) market.
Regional Analysis: The report involves examining the Angiotensin Receptor Blockers (ARBs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Angiotensin Receptor Blockers (ARBs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Angiotensin Receptor Blockers (ARBs):
Company Analysis: Report covers individual Angiotensin Receptor Blockers (ARBs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Angiotensin Receptor Blockers (ARBs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hypertension, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to Angiotensin Receptor Blockers (ARBs). It assesses the current state, advancements, and potential future developments in Angiotensin Receptor Blockers (ARBs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Angiotensin Receptor Blockers (ARBs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Angiotensin Receptor Blockers (ARBs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Angiotensin Receptor Blockers (ARBs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Angiotensin Receptor Blockers (ARBs), with price, sales, revenue and global market share of Angiotensin Receptor Blockers (ARBs) from 2019 to 2024.
Chapter 3, the Angiotensin Receptor Blockers (ARBs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin Receptor Blockers (ARBs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Angiotensin Receptor Blockers (ARBs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Angiotensin Receptor Blockers (ARBs).
Chapter 14 and 15, to describe Angiotensin Receptor Blockers (ARBs) sales channel, distributors, customers, research findings and conclusion.
Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Angiotensin Receptor Blockers (ARBs) industry chain, the market status of Hypertension (Valsartan, Telmisartan), Cardiovascular Diseases (Valsartan, Telmisartan), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Angiotensin Receptor Blockers (ARBs).
Regionally, the report analyzes the Angiotensin Receptor Blockers (ARBs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Angiotensin Receptor Blockers (ARBs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Angiotensin Receptor Blockers (ARBs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Angiotensin Receptor Blockers (ARBs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Valsartan, Telmisartan).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Angiotensin Receptor Blockers (ARBs) market.
Regional Analysis: The report involves examining the Angiotensin Receptor Blockers (ARBs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Angiotensin Receptor Blockers (ARBs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Angiotensin Receptor Blockers (ARBs):
Company Analysis: Report covers individual Angiotensin Receptor Blockers (ARBs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Angiotensin Receptor Blockers (ARBs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hypertension, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to Angiotensin Receptor Blockers (ARBs). It assesses the current state, advancements, and potential future developments in Angiotensin Receptor Blockers (ARBs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Angiotensin Receptor Blockers (ARBs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Angiotensin Receptor Blockers (ARBs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Valsartan
- Telmisartan
- Losartan
- Irbesartan
- Azilsartan
- Olmesartan
- Hypertension
- Cardiovascular Diseases
- Kidney Diseases
- Other
- Pfizer
- Novartis
- Merck
- Astra Zeneca
- Jhonson and Johnson
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- GSK
- Teva Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Angiotensin Receptor Blockers (ARBs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Angiotensin Receptor Blockers (ARBs), with price, sales, revenue and global market share of Angiotensin Receptor Blockers (ARBs) from 2019 to 2024.
Chapter 3, the Angiotensin Receptor Blockers (ARBs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin Receptor Blockers (ARBs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Angiotensin Receptor Blockers (ARBs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Angiotensin Receptor Blockers (ARBs).
Chapter 14 and 15, to describe Angiotensin Receptor Blockers (ARBs) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Angiotensin Receptor Blockers (ARBs)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Valsartan
1.3.3 Telmisartan
1.3.4 Losartan
1.3.5 Irbesartan
1.3.6 Azilsartan
1.3.7 Olmesartan
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hypertension
1.4.3 Cardiovascular Diseases
1.4.4 Kidney Diseases
1.4.5 Other
1.5 Global Angiotensin Receptor Blockers (ARBs) Market Size & Forecast
1.5.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity (2019-2030)
1.5.3 Global Angiotensin Receptor Blockers (ARBs) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Product and Services
2.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Product and Services
2.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Angiotensin Receptor Blockers (ARBs) Product and Services
2.3.4 Merck Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Astra Zeneca
2.4.1 Astra Zeneca Details
2.4.2 Astra Zeneca Major Business
2.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Services
2.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astra Zeneca Recent Developments/Updates
2.5 Jhonson and Johnson
2.5.1 Jhonson and Johnson Details
2.5.2 Jhonson and Johnson Major Business
2.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Services
2.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Jhonson and Johnson Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Services
2.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Product and Services
2.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Services
2.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers Squibb Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Product and Services
2.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bayer Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Angiotensin Receptor Blockers (ARBs) Product and Services
2.10.4 GSK Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Services
2.11.4 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Teva Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) BY MANUFACTURER
3.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer (2019-2024)
3.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Angiotensin Receptor Blockers (ARBs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Angiotensin Receptor Blockers (ARBs) Manufacturer Market Share in 2023
3.4.2 Top 6 Angiotensin Receptor Blockers (ARBs) Manufacturer Market Share in 2023
3.5 Angiotensin Receptor Blockers (ARBs) Market: Overall Company Footprint Analysis
3.5.1 Angiotensin Receptor Blockers (ARBs) Market: Region Footprint
3.5.2 Angiotensin Receptor Blockers (ARBs) Market: Company Product Type Footprint
3.5.3 Angiotensin Receptor Blockers (ARBs) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Region
4.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2030)
4.1.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2030)
4.1.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2019-2030)
4.2 North America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.3 Europe Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.4 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.5 South America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.6 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
5.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2019-2030)
5.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
6.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2019-2030)
6.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
7.2 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
7.3 North America Angiotensin Receptor Blockers (ARBs) Market Size by Country
7.3.1 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
7.3.2 North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
8.2 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
8.3 Europe Angiotensin Receptor Blockers (ARBs) Market Size by Country
8.3.1 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
8.3.2 Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Size by Region
9.3.1 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
10.2 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
10.3 South America Angiotensin Receptor Blockers (ARBs) Market Size by Country
10.3.1 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
10.3.2 South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Market Size by Country
11.3.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Angiotensin Receptor Blockers (ARBs) Market Drivers
12.2 Angiotensin Receptor Blockers (ARBs) Market Restraints
12.3 Angiotensin Receptor Blockers (ARBs) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Angiotensin Receptor Blockers (ARBs) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiotensin Receptor Blockers (ARBs)
13.3 Angiotensin Receptor Blockers (ARBs) Production Process
13.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiotensin Receptor Blockers (ARBs) Typical Distributors
14.3 Angiotensin Receptor Blockers (ARBs) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Angiotensin Receptor Blockers (ARBs)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Valsartan
1.3.3 Telmisartan
1.3.4 Losartan
1.3.5 Irbesartan
1.3.6 Azilsartan
1.3.7 Olmesartan
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hypertension
1.4.3 Cardiovascular Diseases
1.4.4 Kidney Diseases
1.4.5 Other
1.5 Global Angiotensin Receptor Blockers (ARBs) Market Size & Forecast
1.5.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity (2019-2030)
1.5.3 Global Angiotensin Receptor Blockers (ARBs) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Product and Services
2.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Product and Services
2.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Angiotensin Receptor Blockers (ARBs) Product and Services
2.3.4 Merck Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Astra Zeneca
2.4.1 Astra Zeneca Details
2.4.2 Astra Zeneca Major Business
2.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Services
2.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astra Zeneca Recent Developments/Updates
2.5 Jhonson and Johnson
2.5.1 Jhonson and Johnson Details
2.5.2 Jhonson and Johnson Major Business
2.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Services
2.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Jhonson and Johnson Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Services
2.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Product and Services
2.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanofi Recent Developments/Updates
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Services
2.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers Squibb Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Product and Services
2.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bayer Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Angiotensin Receptor Blockers (ARBs) Product and Services
2.10.4 GSK Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Services
2.11.4 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Teva Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) BY MANUFACTURER
3.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer (2019-2024)
3.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Angiotensin Receptor Blockers (ARBs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Angiotensin Receptor Blockers (ARBs) Manufacturer Market Share in 2023
3.4.2 Top 6 Angiotensin Receptor Blockers (ARBs) Manufacturer Market Share in 2023
3.5 Angiotensin Receptor Blockers (ARBs) Market: Overall Company Footprint Analysis
3.5.1 Angiotensin Receptor Blockers (ARBs) Market: Region Footprint
3.5.2 Angiotensin Receptor Blockers (ARBs) Market: Company Product Type Footprint
3.5.3 Angiotensin Receptor Blockers (ARBs) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Region
4.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2030)
4.1.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2030)
4.1.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2019-2030)
4.2 North America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.3 Europe Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.4 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.5 South America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
4.6 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
5.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2019-2030)
5.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
6.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2019-2030)
6.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
7.2 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
7.3 North America Angiotensin Receptor Blockers (ARBs) Market Size by Country
7.3.1 North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
7.3.2 North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
8.2 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
8.3 Europe Angiotensin Receptor Blockers (ARBs) Market Size by Country
8.3.1 Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
8.3.2 Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Size by Region
9.3.1 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
10.2 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
10.3 South America Angiotensin Receptor Blockers (ARBs) Market Size by Country
10.3.1 South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
10.3.2 South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Market Size by Country
11.3.1 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Angiotensin Receptor Blockers (ARBs) Market Drivers
12.2 Angiotensin Receptor Blockers (ARBs) Market Restraints
12.3 Angiotensin Receptor Blockers (ARBs) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Angiotensin Receptor Blockers (ARBs) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiotensin Receptor Blockers (ARBs)
13.3 Angiotensin Receptor Blockers (ARBs) Production Process
13.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiotensin Receptor Blockers (ARBs) Typical Distributors
14.3 Angiotensin Receptor Blockers (ARBs) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 2. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Angiotensin Receptor Blockers (ARBs) Product and Services
Table 6. Pfizer Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Angiotensin Receptor Blockers (ARBs) Product and Services
Table 11. Novartis Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Angiotensin Receptor Blockers (ARBs) Product and Services
Table 16. Merck Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 19. Astra Zeneca Major Business
Table 20. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Services
Table 21. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Astra Zeneca Recent Developments/Updates
Table 23. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Jhonson and Johnson Major Business
Table 25. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Services
Table 26. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Jhonson and Johnson Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Services
Table 31. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Angiotensin Receptor Blockers (ARBs) Product and Services
Table 36. Sanofi Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Services
Table 41. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers Squibb Recent Developments/Updates
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Angiotensin Receptor Blockers (ARBs) Product and Services
Table 46. Bayer Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bayer Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Angiotensin Receptor Blockers (ARBs) Product and Services
Table 51. GSK Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceutical Major Business
Table 55. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Services
Table 56. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Teva Pharmaceutical Recent Developments/Updates
Table 58. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 59. Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 61. Market Position of Manufacturers in Angiotensin Receptor Blockers (ARBs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Angiotensin Receptor Blockers (ARBs) Production Site of Key Manufacturer
Table 63. Angiotensin Receptor Blockers (ARBs) Market: Company Product Type Footprint
Table 64. Angiotensin Receptor Blockers (ARBs) Market: Company Product Application Footprint
Table 65. Angiotensin Receptor Blockers (ARBs) New Market Entrants and Barriers to Market Entry
Table 66. Angiotensin Receptor Blockers (ARBs) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 68. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 69. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2019-2024) & (USD/MT)
Table 72. Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2025-2030) & (USD/MT)
Table 73. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 74. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 75. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2024) & (USD/MT)
Table 78. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2025-2030) & (USD/MT)
Table 79. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 80. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 81. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2024) & (USD/MT)
Table 84. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2025-2030) & (USD/MT)
Table 85. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 86. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 87. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 88. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 89. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 90. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 91. North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 94. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 95. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 96. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 97. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 98. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 99. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 102. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 103. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 104. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 105. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 106. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 107. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 110. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 111. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 112. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 113. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 114. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 115. South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 118. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 119. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 120. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 121. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 122. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 123. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Angiotensin Receptor Blockers (ARBs) Raw Material
Table 126. Key Manufacturers of Angiotensin Receptor Blockers (ARBs) Raw Materials
Table 127. Angiotensin Receptor Blockers (ARBs) Typical Distributors
Table 128. Angiotensin Receptor Blockers (ARBs) Typical Customers
Table 2. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Angiotensin Receptor Blockers (ARBs) Product and Services
Table 6. Pfizer Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Angiotensin Receptor Blockers (ARBs) Product and Services
Table 11. Novartis Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Angiotensin Receptor Blockers (ARBs) Product and Services
Table 16. Merck Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 19. Astra Zeneca Major Business
Table 20. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Services
Table 21. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Astra Zeneca Recent Developments/Updates
Table 23. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Jhonson and Johnson Major Business
Table 25. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Services
Table 26. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Jhonson and Johnson Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Services
Table 31. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Angiotensin Receptor Blockers (ARBs) Product and Services
Table 36. Sanofi Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanofi Recent Developments/Updates
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Services
Table 41. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers Squibb Recent Developments/Updates
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Angiotensin Receptor Blockers (ARBs) Product and Services
Table 46. Bayer Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bayer Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Angiotensin Receptor Blockers (ARBs) Product and Services
Table 51. GSK Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Teva Pharmaceutical Major Business
Table 55. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Services
Table 56. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Teva Pharmaceutical Recent Developments/Updates
Table 58. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 59. Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 61. Market Position of Manufacturers in Angiotensin Receptor Blockers (ARBs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Angiotensin Receptor Blockers (ARBs) Production Site of Key Manufacturer
Table 63. Angiotensin Receptor Blockers (ARBs) Market: Company Product Type Footprint
Table 64. Angiotensin Receptor Blockers (ARBs) Market: Company Product Application Footprint
Table 65. Angiotensin Receptor Blockers (ARBs) New Market Entrants and Barriers to Market Entry
Table 66. Angiotensin Receptor Blockers (ARBs) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 68. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 69. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2019-2024) & (USD/MT)
Table 72. Global Angiotensin Receptor Blockers (ARBs) Average Price by Region (2025-2030) & (USD/MT)
Table 73. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 74. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 75. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2024) & (USD/MT)
Table 78. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2025-2030) & (USD/MT)
Table 79. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 80. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 81. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2024) & (USD/MT)
Table 84. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2025-2030) & (USD/MT)
Table 85. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 86. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 87. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 88. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 89. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 90. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 91. North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 94. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 95. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 96. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 97. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 98. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 99. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 102. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 103. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 104. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 105. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 106. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 107. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 110. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 111. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 112. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 113. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2019-2024) & (K MT)
Table 114. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity by Country (2025-2030) & (K MT)
Table 115. South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Angiotensin Receptor Blockers (ARBs) Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2019-2024) & (K MT)
Table 118. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Type (2025-2030) & (K MT)
Table 119. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2019-2024) & (K MT)
Table 120. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Application (2025-2030) & (K MT)
Table 121. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2019-2024) & (K MT)
Table 122. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity by Region (2025-2030) & (K MT)
Table 123. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Angiotensin Receptor Blockers (ARBs) Raw Material
Table 126. Key Manufacturers of Angiotensin Receptor Blockers (ARBs) Raw Materials
Table 127. Angiotensin Receptor Blockers (ARBs) Typical Distributors
Table 128. Angiotensin Receptor Blockers (ARBs) Typical Customers
LIST OF FIGURES
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Type in 2023
Figure 4. Valsartan Examples
Figure 5. Telmisartan Examples
Figure 6. Losartan Examples
Figure 7. Irbesartan Examples
Figure 8. Azilsartan Examples
Figure 9. Olmesartan Examples
Figure 10. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Application in 2023
Figure 12. Hypertension Examples
Figure 13. Cardiovascular Diseases Examples
Figure 14. Kidney Diseases Examples
Figure 15. Other Examples
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity (2019-2030) & (K MT)
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Average Price (2019-2030) & (USD/MT)
Figure 20. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Angiotensin Receptor Blockers (ARBs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Angiotensin Receptor Blockers (ARBs) Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Angiotensin Receptor Blockers (ARBs) Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2030) & (USD/MT)
Figure 35. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2030) & (USD/MT)
Figure 38. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 58. China Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Angiotensin Receptor Blockers (ARBs) Market Drivers
Figure 79. Angiotensin Receptor Blockers (ARBs) Market Restraints
Figure 80. Angiotensin Receptor Blockers (ARBs) Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Angiotensin Receptor Blockers (ARBs) in 2023
Figure 83. Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
Figure 84. Angiotensin Receptor Blockers (ARBs) Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Type in 2023
Figure 4. Valsartan Examples
Figure 5. Telmisartan Examples
Figure 6. Losartan Examples
Figure 7. Irbesartan Examples
Figure 8. Azilsartan Examples
Figure 9. Olmesartan Examples
Figure 10. Global Angiotensin Receptor Blockers (ARBs) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Application in 2023
Figure 12. Hypertension Examples
Figure 13. Cardiovascular Diseases Examples
Figure 14. Kidney Diseases Examples
Figure 15. Other Examples
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity (2019-2030) & (K MT)
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Average Price (2019-2030) & (USD/MT)
Figure 20. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Angiotensin Receptor Blockers (ARBs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Angiotensin Receptor Blockers (ARBs) Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Angiotensin Receptor Blockers (ARBs) Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Angiotensin Receptor Blockers (ARBs) Average Price by Type (2019-2030) & (USD/MT)
Figure 35. Global Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Angiotensin Receptor Blockers (ARBs) Average Price by Application (2019-2030) & (USD/MT)
Figure 38. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 58. China Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Angiotensin Receptor Blockers (ARBs) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Angiotensin Receptor Blockers (ARBs) Market Drivers
Figure 79. Angiotensin Receptor Blockers (ARBs) Market Restraints
Figure 80. Angiotensin Receptor Blockers (ARBs) Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Angiotensin Receptor Blockers (ARBs) in 2023
Figure 83. Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
Figure 84. Angiotensin Receptor Blockers (ARBs) Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
More Publications
Global Angiotensin Receptor Blockers (ARBs) Market Growth 2024-2030
US$ 3,660.00
December 2024
114 pages
Global Gamma-Aminobutyric Acid (GABA) Receptor Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
US$ 3,480.00
January 2023
76 pages
Global Neuropeptide Y Receptor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
July 2024
117 pages
Global Metabotropic Glutamate Receptor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
April 2025
86 pages
Global Antihypertensive Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
March 2022
129 pages
